SoftMedx Healthcare Limited (HKEX: 00648, “SoftMedx”) filed its Monthly Return for Equity Issuer for the period ended 30 June 2026 with Hong Kong Exchanges and Clearing Limited on 6 July 2026.
• Share capital status – Issued ordinary shares (excluding treasury shares) remained unchanged at 107.12 million. – The company held no treasury shares. – Consequently, total issued shares at month-end were stable at 107.12 million.
• Capital movements – The filing recorded no issuance, cancellation, conversion or repurchase of shares during the month. – No activity was reported under share option schemes, warrants, convertibles, or other equity-linked agreements.
• Public-float position – SoftMedx confirmed compliance with the Main Board’s minimum public-float requirement of 25% of issued shares as of 30 June 2026.
• Regulatory confirmation – The board affirmed that all regulatory obligations under Hong Kong listing rules and relevant laws were duly met, including receipt of all funds for securities issuance (where applicable) and fulfillment of disclosure and filing requirements.
The unchanged share count and confirmation of adequate public float indicate capital stability during the review period, with no dilution or treasury-share activity impacting shareholder interests.
Comments